← Back to Search

Dairy Nutrient

Dairy Milk for Obesity-Related Inflammation (AIMM Trial)

N/A
Recruiting
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Obese (BMI, body mass index ≥30, <40 kg•m-2)
Age 40-59
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-5 hours postprandial observation period to ingesting 2 servings of respective arm.
Awards & highlights

AIMM Trial Summary

This trial will test whether or not dairy full-fat milk will help improve problems caused by obesity such as inflammation, metabolism, and physical limitations.

Who is the study for?
This trial is for obese individuals aged 40-59 who have been weight stable and sedentary for the past six months. Participants must be pre-menopausal women with a BMI between 30 and 40, not using tobacco or drinking heavily. Those with metabolic disorders, cardiovascular diseases, recent surgeries, certain chronic conditions, allergies to dairy or lactose intolerance are excluded.Check my eligibility
What is being tested?
The study tests whether different types of milk (fat-free vs full-fat) can improve muscle health and reduce inflammation in obese individuals. It's a controlled-feeding intervention where participants will consume non-dairy beverages as well as fat-free and full-fat milk to see which has better effects on their metabolism.See study design
What are the potential side effects?
Potential side effects may include digestive discomfort due to lactose content in milk for those who might have undiagnosed lactose sensitivity. Full-fat milk could also affect cholesterol levels given its saturated fat content.

AIMM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is between 30 and 40.
Select...
I am between 40 and 59 years old.
Select...
I have not gone through menopause.

AIMM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-5 hours postprandial observation period to ingesting 2 servings of respective arm.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-5 hours postprandial observation period to ingesting 2 servings of respective arm. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood inflammation markers by flow cytometry.
Fractional synthetic rate of myofibrillar proteins by stable isotope infusion.

AIMM Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Full-fat dairyExperimental Treatment2 Interventions
3x daily servings (cup-eq) of full-fat (3.25%) commercial cow's milk.
Group II: Non-fat diaryActive Control2 Interventions
3x daily servings (cup-eq) of non-fat (0%) commercial cow's milk.
Group III: Non-dairy controlPlacebo Group2 Interventions
3x daily servings (cup-eq) of non-dairy sourced macronutrient composition of full-fat milk.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
188 Previous Clinical Trials
37,299 Total Patients Enrolled
2 Trials studying Inflammation
66 Patients Enrolled for Inflammation

Media Library

Full-fat milk (Dairy Nutrient) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04216004 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Anti-Inflammatory Milk Matrix
Nicholas Burd 2020. "Anti-Inflammatory Milk Matrix". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04216004.
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top